Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of BLVR System in Advanced Upper Lobe Predominant Emphysema
NCT00515164Phase 2Completed
- Sponsor
- Aeris Therapeutics
- Start
- Aug 2007
- Primary completion
- Apr 2008
- Modality
- Polymer-based Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of AeriSeal in pulmonary emphysema, sponsored by Aeris Therapeutics. Started Aug 2007; status: completed.
02
Drugs
AeriSeal
03
Conditions
pulmonary emphysema
Beyond the preview
Go deeper on NCT00515164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00515164.